Sigyn Therapeutics, Inc. (SIGY)

Sigyn Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	0.01	0.01	0.01	0.34	0.08
Cash & Short-Term Investments	0.01	0.01	0.01	0.34	0.08
Cash Growth	3.88%	39.90%	-97.55%	303.97%	-
Inventory	-	0.05	0.05	0.05	0.59
Other Current Assets	0.01	0.06	0.01	0	-
Total Current Assets	0.02	0.12	0.07	0.39	0.67
Property, Plant & Equipment	0.12	0.18	0.24	0.29	0
Other Intangible Assets	-	-	0	0.01	0.02
Other Long-Term Assets	0.07	0.02	0.02	0.02	-
Total Assets	0.21	0.32	0.33	0.71	0.69
Accounts Payable	0.61	0.46	0.33	0.04	0.02
Accrued Expenses	1.87	0.79	0.03	0	0.06
Short-Term Debt	2.07	2.29	1.64	0.65	0.52
Current Portion of Leases	0.07	0.06	0.05	0.05	-
Other Current Liabilities	0	0	0	0	0
Total Current Liabilities	4.61	3.61	2.05	0.73	0.59
Long-Term Leases	0.06	0.13	0.19	0.24	-
Total Liabilities	4.67	3.73	2.24	0.97	0.59
Common Stock	0	0	0	0	0
Additional Paid-In Capital	10.22	7.93	5.29	4	1.36
Retained Earnings	-14.68	-11.34	-7.2	-4.27	-1.26
Shareholders' Equity	-4.46	-3.41	-1.9	-0.26	0.1
Total Liabilities & Equity	0.21	0.32	0.33	0.71	0.69
Total Debt	2.19	2.48	1.88	0.93	0.52
Net Cash (Debt)	-2.18	-2.47	-1.87	-0.59	-0.43
Net Cash Per Share	-1.64	-2.24	-2.00	-0.65	-2.36
Filing Date Shares Outstanding	1.61	1.22	1.07	0.93	0.88
Total Common Shares Outstanding	1.61	1.29	0.96	0.93	0.88
Working Capital	-4.59	-3.49	-1.98	-0.34	0.08
Book Value Per Share	-2.78	-2.65	-1.99	-0.28	0.11
Tangible Book Value	-4.46	-3.41	-1.91	-0.27	0.08
Tangible Book Value Per Share	-2.78	-2.65	-1.99	-0.29	0.09
Machinery	0.03	0.03	0.03	0.03	0

Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.